neostigmine has been researched along with Diabetic Neuropathies in 3 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intrathecal neostigmine produces a profound analgesic effect in a rat model of diabetic neuropathic pain." | 7.71 | Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain. ( Chen, SR; Khan, GM; Pan, HL, 2001) |
| "Intrathecal neostigmine produces a profound analgesic effect in a rat model of diabetic neuropathic pain." | 3.71 | Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain. ( Chen, SR; Khan, GM; Pan, HL, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cellini, J | 1 |
| DiNovo, K | 1 |
| Harlow, J | 1 |
| LePard, KJ | 1 |
| Chen, SR | 1 |
| Khan, GM | 1 |
| Pan, HL | 1 |
| Triantafillou, AN | 1 |
| Tsueda, K | 1 |
| Berg, J | 1 |
| Wieman, TJ | 1 |
3 other studies available for neostigmine and Diabetic Neuropathies
| Article | Year |
|---|---|
Regional differences in neostigmine-induced contraction and relaxation of stomach from diabetic guinea pig.
Topics: Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; | 2011 |
Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathic pain.
Topics: Analgesics; Animals; Cholinesterase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Neuropathi | 2001 |
Refractory bradycardia after reversal of muscle relaxant in a diabetic with vagal neuropathy.
Topics: Autonomic Nervous System Diseases; Blood Pressure; Bradycardia; Diabetic Neuropathies; Glycopyrrolat | 1986 |